EZH2 and MDM2 are critical in lung cancer; the activation of EZH2 accelerates cell growth, promoting rapid tumor progression and facilitating cancer cell dissemination to other organs by inducing EMT, thereby increasing cell mobility and invasiveness. Here, MDM2 is linked to lung cancer.